Halozyme Therapeutics, Inc. (HALO) Social Stream



Halozyme Therapeutics, Inc. (HALO): $41.82

0.16 (+0.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HALO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 387

in industry

HALOZYME THERAPEUTICS INC (HALO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering HALO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 10 $62 $19 $49.444 $41.66 18.68%
2021-11-24 10 $62 $19 $49.222 $41.66 18.15%
2022-01-26 8 $62 $19 $49.285 $41.66 18.3%
2022-02-23 8 $62 $19 $48.714 $41.66 16.93%
2022-05-11 8 $62 $19 $49.428 $41.66 18.65%
2022-05-13 8 $62 $19 $49.142 $41.66 17.96%
2022-05-23 9 $62 $19 $49.5 $41.66 18.82%
2022-05-26 8 $60 $19 $49.25 $41.66 18.22%
2022-06-06 10 $62 $19 $50.666 $41.66 21.62%
2022-08-10 7 $60 $21 $50 $41.66 20.02%
2022-08-15 8 $60 $21 $50 $41.66 20.02%
2022-09-09 9 $60 $21 $50 $41.66 20.02%

The Trend in the Analyst Price Target


Over the past 15 months, HALO's average price target has gone down $2.4.

Over the past 44 weeks, HALO's average upside potential has been 25.79%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-24 10 62 19 49.222 35.27 39.56%
2022-05-02 8 62 19 49.428 40.85 21%
2022-05-22 9 62 19 49.500 44.32 11.69%
2022-05-26 10 60 19 49.250 46.60 5.69%
2022-05-26 8 62 19 50.666 46.60 8.73%

HALO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.61 6 1 1 0 0 9

The Trend in the Broker Recommendations


HALO's average broker recommendation rating improved by 0.13 over the prior 27 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HALO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, HALOZYME THERAPEUTICS INC's variance in analysts' estimates is lower than -1490.44% of them.
  • HALO has a higher upside potential (average analyst target price relative to current price) than 394.69% of all US stocks.
  • HALOZYME THERAPEUTICS INC's number of analysts covering the stock is higher than 1368.8% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, HALOZYME THERAPEUTICS INC's average analyst price target is higher than 1317.81% of them.

In the Pharmaceutical Products industry, FMTX, FATE, and EXAI are the three stocks most similar to HALOZYME THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is HALO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5301 seconds.